{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:54:58Z","timestamp":1785804898346,"version":"3.56.0"},"reference-count":39,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015974","name":"Istituto di Ricerche Farmacologiche Mario Negri","doi-asserted-by":"crossref","award":["Intramural funding"],"award-info":[{"award-number":["Intramural funding"]}],"id":[{"id":"10.13039\/100015974","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Previous studies provided evidence for the alteration of brain cholesterol homeostasis in 129.Mecp2-null mice, an experimental model of Rett syndrome. The efficacy of statins in improving motor symptoms and prolonging survival of mutant mice suggested a potential role of statins in the therapy of Rett syndrome. In the present study, we show that Mecp2 deletion had no effect on brain and reduced serum cholesterol levels and lovastatin (1.5 mg\/kg, twice weekly as in the previous study) had no effects on motor deficits and survival when Mecp2 deletion was expressed on a background strain (C57BL\/6J; B6) differing from that used in the earlier study. These findings indicate that the effects of statins may be background specific and raise important issues to consider when contemplating clinical trials. The reduction of the brain cholesterol metabolite 24S-hydroxycholesterol (24S-OHC) found in B6.Mecp2-null mice suggests the occurrence of changes in brain cholesterol metabolism and the potential utility of using plasma levels of 24S-OHC as a biomarker of brain cholesterol homeostasis in RTT.<\/jats:p>","DOI":"10.7554\/elife.22409","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T08:00:22Z","timestamp":1480320022000},"source":"Crossref","is-referenced-by-count":19,"title":["Lovastatin fails to improve motor performance and survival in methyl-CpG-binding protein2-null mice"],"prefix":"10.7554","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6334-9013","authenticated-orcid":true,"given":"Claudia","family":"Villani","sequence":"first","affiliation":[{"name":"Laboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Sacchetti","sequence":"additional","affiliation":[{"name":"Laboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Bagnati","sequence":"additional","affiliation":[{"name":"Analytical Instrumentation Unit, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Passoni","sequence":"additional","affiliation":[{"name":"Analytical Instrumentation Unit, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Fusco","sequence":"additional","affiliation":[{"name":"Genetics of Neurodegenerative Diseases Unit, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Carli","sequence":"additional","affiliation":[{"name":"Laboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6017-9781","authenticated-orcid":true,"given":"Roberto William","family":"Invernizzi","sequence":"additional","affiliation":[{"name":"Laboratory of Neurochemistry and Behaviour, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nature Genetics"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0021-9150(97)00188-3","article-title":"Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor","volume":"135","author":"Bischoff","year":"1997","journal-title":"Atherosclerosis"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"18J","DOI":"10.1016\/S0002-9149(98)00433-0","article-title":"Preclinical and clinical pharmacology of cerivastatin","volume":"82","author":"Bischoff","year":"1998","journal-title":"The American Journal of Cardiology"},{"key":"bib4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","article-title":"Cholesterol homeostasis in human brain: turnover of 24s-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation","volume":"39","author":"Bj\u00f6rkhem","year":"1998","journal-title":"Journal of Lipid Research"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng.2714","article-title":"A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome","volume":"45","author":"Buchovecky","year":"2013","journal-title":"Nature Genetics"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hipo.22360","article-title":"Excitation\/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice","volume":"25","author":"Calfa","year":"2015","journal-title":"Hippocampus"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.1523\/JNEUROSCI.1816-05.2005","article-title":"Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression","volume":"25","author":"Cervo","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1124\/dmd.107.015677","article-title":"P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a\/b knockout and wild-type mice","volume":"35","author":"Chen","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s002130050327","article-title":"Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies","volume":"132","author":"Crawley","year":"1997","journal-title":"Psychopharmacology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"PNAS"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature10907","article-title":"Wild-type microglia arrest pathology in a mouse model of Rett syndrome","volume":"484","author":"Derecki","year":"2012","journal-title":"Nature"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.neuron.2012.12.004","article-title":"NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2","volume":"76","author":"Durand","year":"2012","journal-title":"Neuron"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"e56599","DOI":"10.1371\/journal.pone.0056599","article-title":"Revealing the complexity of a monogenic disease: rett syndrome exome sequencing","volume":"8","author":"Grillo","year":"2013","journal-title":"PLoS One"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nature Genetics"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"e27265","DOI":"10.4161\/rdis.27265","article-title":"A role for metabolism in Rett syndrome pathogenesis: New clinical findings and potential treatment targets","volume":"1","author":"Justice","year":"2013","journal-title":"Rare Diseases"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"Journal of the American Statistical Association"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Disease Models & Mechanisms"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biology"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1172\/JCI109938","article-title":"Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase","volume":"66","author":"Kita","year":"1980","journal-title":"Journal of Clinical Investigation"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"13860","DOI":"10.1523\/JNEUROSCI.2159-12.2012","article-title":"Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with Ketamine treatment","volume":"32","author":"Kron","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"ddw156","DOI":"10.1093\/hmg\/ddw156","article-title":"MeCP2 co-ordinates liver lipid metabolism with the NCoR1\/HDAC3 corepressor complex","volume":"25","author":"Kyle","year":"2016","journal-title":"Human Molecular Genetics"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.biochi.2012.09.025","article-title":"24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases","volume":"95","author":"Leoni","year":"2013","journal-title":"Biochimie"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1172\/JCI78167","article-title":"MECP2 disorders: from the clinic to mice and back","volume":"125","author":"Lombardi","year":"2015","journal-title":"Journal of Clinical Investigation"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2016.10.021","article-title":"Suppression of brain cholesterol synthesis in male Mecp2-deficient mice is age dependent and not accompanied by a concurrent change in the rate of fatty acid synthesis","volume":"1654","author":"Lopez","year":"2017","journal-title":"Brain Research"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"9947","DOI":"10.1073\/pnas.1309426111","article-title":"\u03b22-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome","volume":"111","author":"Mellios","year":"2014","journal-title":"PNAS"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cub.2006.02.062","article-title":"MeCP2-dependent transcriptional repression regulates excitatory neurotransmission","volume":"16","author":"Nelson","year":"2006","journal-title":"Current Biology"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"17290","DOI":"10.1523\/JNEUROSCI.2619-13.2013","article-title":"The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors","volume":"33","author":"Paul","year":"2013","journal-title":"Journal of Neuroscience"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/eci.12304","article-title":"Most appropriate animal models to study the efficacy of statins: a systematic review","volume":"44","author":"Pecoraro","year":"2014","journal-title":"European Journal of Clinical Investigation"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Progress in Lipid Research"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/FBP.0b013e32830c3645","article-title":"Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches","volume":"19","author":"Ricceri","year":"2008","journal-title":"Behavioural Pharmacology"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/hmg\/dds406","article-title":"Female Mecp2(+\/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies","volume":"22","author":"Samaco","year":"2013","journal-title":"Human Molecular Genetics"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"e104834","DOI":"10.1371\/journal.pone.0104834","article-title":"Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary cultured fibroblasts derived from patients","volume":"9","author":"Segatto","year":"2014","journal-title":"PLoS One"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.conb.2011.06.006","article-title":"Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met","volume":"21","author":"Shepherd","year":"2011","journal-title":"Current Opinion in Neurobiology"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.neuron.2016.08.013","article-title":"Genetic background limits generalizability of genotype-phenotype relationships","volume":"91","author":"Sittig","year":"2016","journal-title":"Neuron"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neuroscience.2007.02.009","article-title":"Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome","volume":"146","author":"Stearns","year":"2007","journal-title":"Neuroscience"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature14444","article-title":"Wild-type microglia do not reverse pathology in mouse models of Rett syndrome","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1016\/j.febslet.2006.07.027","article-title":"Defects of cholesterol biosynthesis","volume":"580","author":"Waterham","year":"2006","journal-title":"FEBS Letters"}],"updated-by":[{"DOI":"10.7554\/elife.38909","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000}}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/22409\/elife-22409-v3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/22409\/elife-22409-v3.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/22409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:58:51Z","timestamp":1697057931000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/22409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":39,"alternative-id":["10.7554\/eLife.22409"],"URL":"https:\/\/doi.org\/10.7554\/elife.22409","archive":["CLOCKSS"],"relation":{"has-review":[{"id-type":"doi","id":"10.7554\/eLife.22409.017","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.22409.018","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]},"article-number":"e22409"}}